95 results
8-K
EX-1.1
WINT
Windtree Therapeutics Inc
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
. There is no pending, completed or, to the Company's knowledge, threatened, action (including any lawsuit, arbitration, or legal or administrative
424B5
WINT
Windtree Therapeutics Inc
9 Nov 23
Prospectus supplement for primary offering
4:11pm
from bringing a lawsuit against our directors and officers for breach of their fiduciary duty. They may also reduce the likelihood of derivative
8-K
EX-1.1
WINT
Windtree Therapeutics Inc
24 Apr 23
Entry into a Material Definitive Agreement
4:40pm
, threatened, action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation
424B4
po63yfp
20 Apr 23
Prospectus supplement with pricing info
6:03pm
8-K
EX-1.1
f6n0h h9snr0xjwat
24 Mar 21
Entry into a Material Definitive Agreement
5:20pm
8-K
EX-10.1
dhzhzjz
23 Jul 20
Departure of Directors or Certain Officers
4:55pm
424B4
tafq0cbcpuan6t7fst0
21 May 20
Prospectus supplement with pricing info
6:04am